Founded in 2006, 23andMe is a leader in personal genomics and biotechnology based in South San Francisco, California. The company, valued at $1.75 billion as of 2017, has raised over $850 million in funding.
23andMe offers DNA testing kits for ancestry and health, with a database of 12 million users. The company partners with pharmaceuticals like GlaxoSmithKline for drug development, contributing to medical research. Known for its FDA-approved health reports, 23andMe faced regulatory challenges but adapted its services accordingly.
The company emphasizes consumer privacy and control over DNA data, allowing users to contribute to research while protecting their information. 23andMe is tagged under genomics.
Recent brand deals include Sorgulayan Sivaslı, Çürük Çapulcu, Naz Ahmed, American Korean Couple and Sorgulayan Teyze. You can request access to our brand deal research below for a complete report.